Denali Therapeutics Inc.

DNLI · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $3.2B · 503 employees
150
SEC Filings
$20.47
Close 2026-09-21
503
Employees

Business Summary

Denali Therapeutics Inc. is a clinical-stage biotherapeutics company focused on developing medicines for neurodegenerative diseases, lysosomal storage disorders, and other serious diseases. The company has invented a proprietary TransportVehicle (TV) platform to deliver large molecules across the blood-brain barrier. Key programs include tividenofusp alfa (ETV:IDS) for Hunter syndrome under FDA BLA priority review, DNL126 for Sanfilippo syndrome, DNL628 for Alzheimer's disease, and BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson's disease.

Latest Stock Quote

DNLI 2026-09-21 $20.47 O:$19.99 H:$20.55 L:$19.4 Vol:2.4M VWAP:$20.1324
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001714899-26-000021EDGAR96K words
2025-02-272024-12-310001714899-25-000066EDGAR96K words
2024-02-282023-12-310001714899-24-000086EDGAR100K words
2023-02-272022-12-310001714899-23-000049EDGAR103K words
2022-02-282021-12-310001714899-22-000058EDGAR110K words
2021-02-262020-12-310001714899-21-000033EDGAR110K words
2020-02-272019-12-310001714899-20-000026EDGAR99K words
2019-03-122018-12-310001714899-19-000015EDGAR99K words
2018-03-192017-12-310001193125-18-086723EDGAR99K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001714899-26-000097EDGAR21K words
2025-11-062025-09-300001714899-25-000193EDGAR53K words
2025-08-112025-06-300001714899-25-000170EDGAR52K words
2025-05-062025-03-310001714899-25-000105EDGAR51K words
2024-11-062024-09-300001714899-24-000216EDGAR57K words
2024-08-012024-06-300001714899-24-000169EDGAR57K words
2024-05-072024-03-310001714899-24-000121EDGAR55K words
2023-11-072023-09-300001714899-23-000146EDGAR60K words
2023-08-082023-06-300001714899-23-000120EDGAR60K words
2023-05-082023-03-310001714899-23-000075EDGAR57K words
2022-11-032022-09-300001714899-22-000144EDGAR62K words
2022-08-082022-06-300001714899-22-000123EDGAR62K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001714899-26-000096EDGAR4K words
2026-07-280001714899-26-000086EDGAR1K words
2026-04-030001714899-26-000042EDGAR1K words
2026-03-310001714899-26-000036EDGAR1K words
2026-03-250001714899-26-000030EDGAR3K words
2026-02-260001714899-26-000020EDGAR3K words
2026-01-060001714899-26-000004EDGAR2K words
2025-12-100001628280-25-056363EDGAR1K words
2025-12-040001714899-25-000209EDGAR13K words
2025-12-040001714899-25-000208EDGAR1K words

150 total filings indexed. 119 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

lysosomal-storage-diseases neurodegenerative-diseases alzheimer's-disease parkinson's-disease frontotemporal-dementia rare-diseases oncology inflammatory-diseases-(ulcerative-colitis) chinese-hamster-ovary-(cho)-cell-culture-manufacturing protein-a-affinity-purification accelerated-approval-pathway-(fda-surrogate-biomarker) biologics-license-application-(bla)

Company Identity

CIK0001714899
TickerDNLI
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
HeadquartersSouth San Francisco, California
Websitehttps://www.denalitherapeutics.com
Listed2017-12-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 91c653204b4b251312f89400d2bcc5d1be74b673b16f7fae32ffcc981442426a
parent: 3ea38bca66a94a54cd82246a4be82f2b0eb7304f4e4a0e4fb2d116a38001d441
content hash: c5450d4431a4be93264709ff4c181a8924e8b32fce8d319dc012ae84d0540ddb
signed: 2026-10-13T19:01:03.815Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up DNLI using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on DNLI, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/DNLI (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.